Lichen Planopilaris. Cicatricial alopecia [scarring hair loss]
Conditions
Interventions
Intervention 1: Control group: 10 patients were injected with 3 cc of triamcinolone (Jaber Ebne Hayyan company) 5 times with a 1-month interval. Intervention 2: Intervention group: 10 patients are inj
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age between 18-60 years Lichen planopilaris disease has been proven
Exclusion criteria
Exclusion criteria: breastfeeding pregnancy Infectious diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response to treatment. Timepoint: 0 and 6 months after the start of the study. Method of measurement: Lichen plano pilaris activity index.;The amount of hair loss. Timepoint: Before starting treatment and one month after the end of the treatment period. Method of measurement: Trichoscan. | — |
Secondary
| Measure | Time frame |
|---|---|
| The level of satisfaction with treatment qualitatively. Timepoint: 2 and 6 months after the start of treatment. Method of measurement: In the qualitative questionnaire (excellent effect, good, medium, low, ineffective).;Side effects. Timepoint: Before starting treatment and one month after the end of the treatment period. Method of measurement: Questionnaire and visit.;Effectiveness. Timepoint: Before starting treatment and one month after the end of the treatment period. Method of measurement: Questionnaire and visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem cell Research Center of Tehran University of Medical Sciences
Outcome results
None listed